Lutetium-177 PSMA617 theranostics in metastatic castrate-resistant prostate cancer (mCRPC): Interim results of a phase II trial.

被引：0
|
作者：
Sandhu, Shahneen Kaur
Violet, John A.
Ferdinandus, Justin
Thang, Sue-Ping
Iravani, Amir
Guo, Christina
Kong, Grace
Kumar, Aravind Ravi
Akhurst, Timothy J.
Beaulieu, Alexis
Murphy, Declan G.
Mooi, Jennifer
Tran, Ben
Toner, Guy C.
Williams, Scott
Hicks, Rodney J.
Hofman, Michael
机构：
[1] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Dept Canc Imaging, Melbourne, Vic, Australia
[4] Peter MacCallum Canc Ctr, Dept Canc Surg, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.5040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5040
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Predictors of better response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Ferdinandus, Justin
    Eppard, Elisabeth
    Kuerpig, Stefan
    Gaertner, Florian
    Fimmers, Rolf
    Hauser, Stefan
    Essler, Markus
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [22] PHASE II TRIAL OF CIRCULATING CYTOKINES AS MARKERS OF DOCETAXEL RESISTANCE IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER (mCRPC)
    Mahon, Kate
    Lin, H-M
    Spielman, C.
    Lee-Ng, M.
    Gurney, H.
    Mallesara, G.
    Stockler, M.
    Briscoe, K.
    Marx, G.
    Breit, S. N.
    Brown, D.
    Horvath, L.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 37 - 37
  • [23] Final results of phase I/II trial of fractionated dose 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer (mCRPC)
    Tagawa, S. T.
    Sun, M.
    Sartor, O.
    Thomas, C.
    Molina, A. M.
    Sternberg, C. N.
    Nanus, D. M.
    Osborne, J.
    Bander, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S645 - S645
  • [24] Predictors of better response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Ferdinandus, J.
    Eppard, E.
    Kuerpig, S.
    Gaertner, F.
    Fimmers, R.
    Yordanova, A.
    Hauser, S.
    Essler, M.
    Feldmann, G.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S212 - S213
  • [25] EVALUATION OF RESPONSE TO 177LU-PSMA-617 BY SITE SPECIFIC DISEASE IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
    Mahmoud, Ahmed M.
    Ahmed, Mohamed E.
    Abdelrazek, Ahmad
    Childs, Daniel
    Kendi, Ayse T.
    Johnson, Geoffrey
    Karnes, Jeffrey
    Kwon, Eugene
    Andrews, Jack
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1004 - E1004
  • [26] Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    Sartor, Oliver
    de Bono, Johann
    Chi, Kim N.
    Fizazi, Karim
    Herrmann, Ken
    Rahbar, Kambiz
    Tagawa, Scott T.
    Nordquist, Luke T.
    Vaishampayan, Nitin
    El-Haddad, Ghassan
    Park, Chandler H.
    Beer, Tomasz M.
    Armour, Alison
    Perez-Contreras, Wendy J.
    DeSilvio, Michelle
    Kpamegan, Euloge
    Gericke, Germo
    Messmann, Richard A.
    Morris, Michael J.
    Krause, Bernd J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12): : 1091 - 1103
  • [27] EVALUATION OF RESPONSE TO 177LU-PSMA-617 BY SITE SPECIFIC DISEASE IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
    Mohamed, E. Ahmed
    Giuseppe, Reitano
    Ahmed, Mahmoud
    Umar, Ghaffar
    Tuba, Kendi Ayse
    Jeffrey, Karnes R.
    Eugene, Kwon
    Jack, Andrews
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [28] Patient outcomes after therapy with 177Lu-PSMA-617 (LuPSMA) for metastatic castrate-resistant prostate cancer (mCRPC): A tertiary center experience.
    Vaz, Nuno
    Ritzer, Jolivette
    Wolanski, Andrew
    Bhimaniya, Sudhir
    Choudhury, Atish Dipankar
    Hyun, Hyewon
    Kelly, Emma
    Kilbridge, Kerry L.
    Morgans, Alicia K.
    Pomerantz, Mark
    Robertson, Matthew
    Sakellis, Christopher
    Shah, Hina
    Sunkara, Rajitha
    Taplin, Mary-Ellen
    Wei, Xiao X.
    Whelpley, Bridget
    Ravi, Praful
    Jacene, Heather
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 87 - 87
  • [29] Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial
    Ardolino, Luke C.
    Dear, Rachel
    Armstrong, Andrew J.
    Gillessen, Silke
    Joshua, Anthony M.
    EUROPEAN UROLOGY, 2023, 84 (04) : E94 - E95
  • [30] Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION Trial
    Morris, Michael J.
    Sartor, Oliver
    de Bono, Johann S.
    Fizazi, Karim
    Tagawa, Scott T.
    EUROPEAN UROLOGY, 2023, 84 (01) : 7 - 8
12345